Achieve Life Sciences, Inc.

Achieve Life Sciences, Inc.

ACHV · Nasdaq

Achieve Life Sciences, Inc. (ACHV) is a Biotechnology company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for Achieve Life Sciences, Inc. in 2026. The next earnings report is expected on November 5, 2026.

Earnings calendar

Next earnings date

05 Nov 2026

In 77 days

EPS estimate

-0.18

Revenue estimate

0

Past earnings

11 Aug 2026
EPS actual
-0.80 (-385.2%)
estimate -0.16
Revenue actual
0
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
12 May 2026
EPS actual
-0.19 (+36.4%)
estimate -0.30
Revenue actual
0
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
24 Mar 2026
EPS actual
-0.28 (+2.8%)
estimate -0.29
Revenue actual
0
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
06 Nov 2025
EPS actual
-0.28 (-14.8%)
estimate -0.24
Revenue actual
0
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
Beat Miss usd

Latest earnings analysis

Achieve Life Sciences, Inc. missed consensus estimates in its latest earnings report, with EPS of USD -0.8 versus an estimate of USD -0.1649 and revenue of USD 0 meeting expectations. In the prior quarter, EPS came in ahead of expectations while revenue also met estimates.

Dividend calendar

No dividend history available.

EPS (Earnings Per Share)

Revenue

Company profile

Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. The company is based in Vancouver, Canada.

Sector
Healthcare
Industry
Biotechnology
Country
Canada
Exchange
Nasdaq
CEO
Richard A. Stewart
Employees
25
IPO date
12 Oct 1995
ISIN
US0044685008
Website
achievelifesciences.com

Frequently asked questions

When does Achieve Life Sciences, Inc. (ACHV) next report earnings?

Achieve Life Sciences, Inc. (ACHV) is scheduled to report earnings on November 5, 2026.

What was Achieve Life Sciences, Inc.'s most recent earnings date?

Achieve Life Sciences, Inc. (ACHV) last reported earnings on August 11, 2026.

Where is Achieve Life Sciences, Inc. stock listed?

Achieve Life Sciences, Inc. (ACHV) is listed on Nasdaq.